Article
02 Jul 2026
DOJ’s 2026 Health Care Fraud Takedown: Why Pharmacies Should Act Before An Audit Becomes An Investigation
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
01 Jul 2026
Rhode Island Joins The PBM Oversight Movement: What Senate Bill 3060 Means For Pharmacies, Health Plans And PBM Regulation
Article
01 Jul 2026
Arizona Joins The Growing Movement To Separate PBMs From Pharmacy Ownership
Article
30 Jun 2026
Cassidy’s 340B Reform Discussion Draft Signals A Shift In The Future Of The 340B Program
Article
29 Jun 2026
West Virginia Board Of Pharmacy Adopts New Inspection Rule: What Pharmacies Need To Know Before July 1, 2026
Article
29 Jun 2026
Florida Takes Aim At CVS Caremark: Why The Sunshine State’s Investigation Could Be A Turning Point For PBM Oversight
Article
26 Jun 2026
Maryland Expands Prescriber–Pharmacist Agreements And Opens New Opportunities For Opioid Use Disorder Treatment
Article
26 Jun 2026
Tennessee’s FAIR Rx Act Litigation: Why Independent Pharmacies Should Watch This PBM Fight Closely
Article
24 Jun 2026
Eli Lilly’s 340B Claims-Data Policy: What Covered Entities Need To Know
Article
24 Jun 2026
Prior Authorization By A Third Party: What Pharmacies Need To Know Before The PBM Audit Comes
Article
24 Jun 2026
CMS Signals The Next Major Phase Of PBM Reform: Why Pharmacies And Plan Sponsors Should Pay Attention Now
Article
24 Jun 2026
HRSA’s 340B Rebate Model Is Moving Faster Than Many Expected: What Covered Entities Should Be Doing Now
Article
23 Jun 2026
Express Scripts Challenges Tennessee Fair Rx Act: Another Attempt To Preserve The Status Quo
Article
09 Jun 2026
Federal And State Program-Integrity Scrutiny Of Pharmacies Is Increasing: What Pharmacies Need To Know
Article
01 Jun 2026
Pharmacy Change Of Ownership Transactions: Why CHOW Must Be Handled Correctly
Article
27 May 2026
The No Surprises Act Is Becoming A Legal And Reimbursement Trap For Providers
Article
17 May 2026
The Evolving Responsibilities Of Pharmacists Amid Rising DEA Investigations: What Pharmacies Need To Know Before Agents Walk Through The Door
Article
11 May 2026
Tennessee’s FAIR Rx Act Marks A Major Escalation In State PBM Reform
Article
06 May 2026
The Illusion Of PBM Transparency: What Plan Sponsors Must Learn From The OPM OIG Audit Of CVS Caremark
Article
06 May 2026
What FDA’s Latest Peptide Action Really Means For Compounding Pharmacies
